Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death

被引:258
作者
Mungrue, IN
Gros, R
You, XM
Pirani, A
Azad, A
Csont, T
Schulz, R
Butany, J
Stewart, DJ
Husain, M
机构
[1] St Michaels Hosp, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada
[2] Univ Alberta, Dept Pediat, Edmonton, AB, Canada
[3] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[5] Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada
[6] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada
关键词
D O I
10.1172/JCI200213265
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Increased inducible nitric oxide synthase (iNOS) expression is a component of the immune response and has been demonstrated in cardiomyocytes in septic shock, myocarditis, transplant rejection, ischemia, and dilated cardiomyopathy. To explore whether the consequences of such expression are adaptive or pathogenic, we have generated a transgenic mouse model conditionally targeting the expression of a human iNOS cDNA to myocardium. Chronic cardiac-specific upregulation of iNOS in transgenic mice led to increased production of peroxynitrite. This was associated with a mild inflammatory cell infiltrate, cardiac Fibrosis, hypertrophy, and dilatation. While iNOS-overexpressing mice infrequently developed overt heart failure, they displayed a high incidence of sudden cardiac death due to bradyarrhythmia. This dramatic cardiac phenotype was rescued by specific attenuation of transgene activity. These data implicate cardiomyocyte NOS overexpression as sufficient to cause cardiomyopathy, bradyarrhythmia, and sudden cardiac death.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 40 条
[1]  
BALLIGAND JL, 1994, J BIOL CHEM, V269, P27580
[2]   Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy [J].
Bia, BL ;
Cassidy, PJ ;
Young, ME ;
Rafael, JA ;
Leighton, B ;
Davies, KE ;
Radda, GK ;
Clarke, K .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (10) :1857-1862
[3]   NITRIC-OXIDE SYNTHASE COMPLEXED WITH DYSTROPHIN AND ABSENT FROM SKELETAL-MUSCLE SARCOLEMMA IN DUCHENNE MUSCULAR-DYSTROPHY [J].
BRENMAN, JE ;
CHAO, DS ;
XIA, HH ;
ALDAPE, K ;
BREDT, DS .
CELL, 1995, 82 (05) :743-752
[4]   Effects of nitric oxide synthase inhibition on basal function and the force-frequency relationship in the normal and failing human heart in vivo [J].
Cotton, JM ;
Kearney, MT ;
MacCarthy, PA ;
Grocott-Mason, RM ;
McClean, DR ;
Heymes, C ;
Richardson, PJ ;
Shah, AM .
CIRCULATION, 2001, 104 (19) :2318-2323
[5]   NITRIC-OXIDE SYNTHASE ACTIVITIES IN HUMAN MYOCARDIUM [J].
DEBELDER, AJ ;
RADOMSKI, MW ;
WHY, HJF ;
RICHARDSON, PJ ;
BUCKNALL, CA ;
SALAS, E ;
MARTIN, JF ;
MONCADA, S .
LANCET, 1993, 341 (8837) :84-85
[6]   VERAPAMIL AMELIORATES THE CLINICAL AND PATHOLOGICAL COURSE OF MURINE MYOCARDITIS [J].
DONG, R ;
LIU, P ;
WEE, L ;
BUTANY, J ;
SOLE, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :2022-2030
[7]   HISTOCHEMICAL METHODS FOR SEPARATE CONSECUTIVE AND SIMULTANEOUS DEMONSTRATION OF ACETYLCHOLINESTERASE AND NOREPINEPHRINE IN CRYOSTAT SECTIONS [J].
ELBADAWI, A ;
SCHENK, EA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1967, 15 (10) :580-&
[8]   TIGHT CONTROL OF GENE-EXPRESSION IN MAMMALIAN-CELLS BY TETRACYCLINE-RESPONSIVE PROMOTERS [J].
GOSSEN, M ;
BUJARD, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5547-5551
[9]  
Guslandi M, 1998, EUR J CLIN INVEST, V28, P904
[10]   Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation [J].
Hagendorff, A ;
Schumacher, B ;
Kirchhoff, S ;
Lüderitz, B ;
Willecke, K .
CIRCULATION, 1999, 99 (11) :1508-1515